SUSPECT
PULMONARY
FIBROSIS
– a common threat for many patients with interstitial lung disease (ILD), that calls for urgent identification and intervention.1–4 Early diagnosis of fibrotic ILDs requires radiological interpretation of HRCT5–8
![SUSPECT PULMONARY FIBROSIS](/sites/default/files/2023-12/radiologist-banner.png)
DISCOVER HOW AND WHY IDENTIFYING FIBROTIC ILDs MATTER
![Progressive pulmonary fibrosis (PPF) Progressive pulmonary fibrosis (PPF)](/sites/default/files/2023-12/progressive-pulmonary-fibrosis-ppf-thumbnail.png)
Progressive pulmonary fibrosis (PPF)
Patients with a range of ILDs may develop PPF, a key driver of irreversible harm and early mortality.1–4
![Recognize key fibrotic ILD features on HRCT scans Recognize key fibrotic ILD features on HRCT scans](/sites/default/files/2023-12/recognize-key-fibrotic-ild-features-on-hrct-scans-thumbnail.png)
Recognize key fibrotic ILD features on HRCT scans
Diagnosis of fibrotic ILD requires radiologist interpretation of HRCT scans.5–8
![Participate in a multidisciplinary team (MDT) Participate in a multidisciplinary team (MDT)](/sites/default/files/2023-12/participate-in-a-multidisciplinary-team-mdt-thumbnail.png)
Participate in a multidisciplinary team (MDT)
A MDT approach that includes a radiologist can help to facilitate early and accurate diagnosis of fibrotic ILDs.9,10
- Flaherty KR, Brown KK, Wells AU, et al. Design of the PF-ILD trial: A double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Respir Res. 2017;4:e000212.
- Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc. 2013;10(4):362–370.
- Caban JJ, Yao J, Bagci U, Mollura DJ. Monitoring pulmonary fibrosis by fusing clinical, physiological, and computed tomography features. Conf Proc IEEE Eng Med Biol Soc. 2011;6216–6219.
- Wells AU, Brown KK, Flaherty KR, et al. What’s in a name? That which we call IPF, by any other name would act the same. Eur Respir J. 2018;51(5):1800692.
- Cottin V, Hirani N, Hotchkin D, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076.
- Cottin V, Valenzuela C. Diagnostic approach of fibrosing interstitial lung diseases of unknown origin. Presse Med. 2020;49(2):104021.
- Chung J, Goldin J. Interpretation of HRCT scans in the diagnosis of IPF: improving communication between pulmonologists and radiologists. Lung. 2018;196(5):561–567.
- Mohning MP, Richards JC, Huie TJ. Idiopathic pulmonary fibrosis: the radiologist’s role in making the diagnosis. Br J Radiol. 2019;92(1099):20181003.
- Walsh SLF. Multidisciplinary evaluation of interstitial lung diseases: current insights. Eur Respir Rev. 2017;26:170002.
- De Sadeleer LJ, Meert C, Yserbyt J, et al. Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: A retrospective observational study of 938 cases. Chest. 2018;153(6):1416–1423.
Resources for patients
![life with pulmonary fibrosis](/sites/default/files/2023-06/life-with-pulmonary-fibrosis.png)
![Life with Pulmonary Fibrosis website logo.](/sites/default/files/2021-07/logo-primary_0.png)
Helping patients and their loved ones to learn more about their condition.
![more than scleroderma](/sites/default/files/2023-06/more-than-scleroderma.png)
![More then scleroderma website logo.](/sites/default/files/2021-07/logo-primary_1.png)
Providing information and resources to help support and guide patients.